Company: DNLI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001714899-25-000066
Chunk: 201

Company: Denali Therapeutics Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 15
Chunk 201
---
ITEM 15.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a) The following documents are filed as part of this report:

1. Financial Statements

See Index to Financial Statements in Part II Item 8 of this Annual Report on Form 10-K.

2. Financial Statement Schedules

All schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto.

3. Exhibits

The documents listed in the Exhibit Index are incorporated by reference or are filed with this report, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

175

Table of Contents

EXHIBIT INDEXIncorporated by ReferenceExhibitNumberDescriptionFormFile No.NumberFiling Date3.1Amended and Restated Certificate of Incorporation of the Registrant.8-K001-383113.112/12/20173.2Amended and Restated Bylaws of the Registrant.8-K001-383113.111/18/20244.1Specimen Common Stock Certificate of the Registrant.S-1/A333-2215224.211/27/20174.3#Form of Pre-Funded Warrant (Amended)10-Q001-383114.15/7/20244.4Description of the Registrant’s Common Stock.———Filed herewith10.1+Form of Indemnification Agreement between the Registrant and each of its directors and executive officers.S-1/A333-22152210.111/27/201710.2+2015 Stock Incentive Plan, as amended, and forms of agreement thereunder.S-1333-22152210.211/13/201710.3+2017 Equity Incentive Plan and forms of agreements thereunder.S-1/A333-22152210.311/27/201710.4+2017 Employee Stock Purchase Plan and form of agreement thereunder.S-1/A333-22152210.412/7/201710.5+Offer Letter between the Registrant and Ryan J. Watts, Ph.D., dated November 10, 2017.S-1333-22152210.511/13/201710.6+Offer Letter between the Registrant and Alexander O. Schuth, M.D., dated November 10, 2017.S-1333-22152210.611/13/201710.8+